Clinical practice of rapid antigen tests for SARS-CoV-2 Omicron variant: a single-center study in China.
Ontology highlight
ABSTRACT: Responding to the fast-spreading SARS-CoV-2 Omicron variant, to improve screening efficiency, rapid antigen tests (RATs) were first added as a supplementary detection method in China in mid-March, 2022. What and how big a role RATs should play need to be supported by clinical data. Here, RAT performance and relevant factors in comparison with nucleic acid amplification tests (NAATs) were assessed in Omicron-infected inpatients. From the NAAT results, nasopharyngeal swabs (NPs) performed better than oropharyngeal swabs (OPs). RATs tested on NAAT positive NPs performed better than those with OP-positive samples. The RAT positivity rate was strongly associated with high levels of N and OFR1ab genes, especially in NPs where patients also had significantly longer hospital stays and shorter days
SUBMITTER: Chen M
PROVIDER: S-EPMC9422342 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA